INDICATIONS AND USAGE
DALIRESP is indicated as a treatment to reduce the risk of COPD exacerbations in
patients with severe COPD associated with chronic bronchitis and a history of exacerbations.
DALIRESP is not a bronchodilator and is not indicated for the relief of acute bronchospasm.
DALIRESP has been shown to reduce the risk of COPD exacerbations.
Sign up to receive updates and information about DALIRESP.